Enter assignee name

EPO Patents = 1

Trademarks = 3

Forward Citations = 18

Loading Chart...

6 inventors (with patents filed for the assignee):

Thomas Claiborne Lovelace (4 out of 6 patents)

Joseph Alexander Moore, Iii (4 out of 8 patents)

Christopher McKinnon Lee (4 out of 4 patents)

4. Daniel Logan Kirschner (4 out of 4 patents)

5. Alexander Smith (3 out of 16 patents)

6. Rostislav Christov Raykov (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12311026 - Therapeutic uses for sodium thiosulfate formulations (2025-05-27),

2. 11998604 - Therapeutic uses for sodium thiosulfate formulations (2024-06-04),

3. 11964018 - Therapeutic uses for sodium thiosulfate formulations (2024-04-23),

4. 11617793 - Anhydrous sodium thiosulfate and formulations thereof (2023-04-04),

5. 11510984 - Anhydrous sodium thiosulfate and formulations thereof (2022-11-29),

6. 11291728 - Anhydrous sodium thiosulfate and formulations thereof (2022-04-05),

7. 10792363 - Anhydrous sodium thiosulfate and formulations thereof (2020-10-06),

Fennec Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate) for the prevention of ototoxicity associated with cisplatin chemotherapy in pediatric patients. The company is dedicated to improving the lives of children undergoing cancer treatment by providing safe and effective therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

7 Patents

#34 in Research Triangle Park, NC

#838 in North Carolina

#38,860 in US

Research Triangle Park, NC, United States of America

Fennec Pharmaceuticals, Inc.